NeuroTherapia has concluded its Phase IIa clinical trial of NTRX-07, an orally available molecule, for Alzheimer's disease ...
CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), today announces a new payer coverage agreement with Highmark, effective April 1, ...
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform ...
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the 'Company”), a clinical-stage pharmaceutical company developing targeted ...
How does the brain clean itself during sleep? A new ultrafast MRI method tracks cerebrospinal fluid flow without contrast ...
Pozzovivo last raced in 2024, finishing 38th at Il Lombardia while riding for VF Group-Bardiani CSF-Faizanè, but now he will ...
Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) ...
Plus Therapeutics, Inc. (NASDAQ:PSTV) is one of the 8 Most Oversold Penny Stocks to Buy Right Now. On March 31, 2026, D.
Trial Designed to Demonstrate Target Engagement, Safety, and Pharmacokinetics CLEVELAND, April 7, 2026 /PRNewswire/ -- NeuroTherapia, Inc., a clinical-stage company focused on developing oral ...
Near-infrared spectroscopy, or fNIRS, offers a way to monitor brain activity without surgery or radiation by tracking changes in blood flow and oxygenation. Light sources placed on the scalp send near ...
Global News - Inquirer.net on MSN
New surgical procedure shown to improve symptoms of moderate Alzheimer’s
SINGAPORE – A new surgical procedure has been shown to improve the behavioral and psychological symptoms associated with mild ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results